Abstract. Abnormal ductal NaCi absorption has been known as the only defect in cystic fibrosis (CF) sweat glands. We have fortuitously found that the secretory portion of CF sweat glands is also abnormal in that it failed to show a sweating response to beta adrenergic stimulation (isoproterenol, [ISO]) both in vivo and in vitro. For the in vitro sweat test, eccrine sweat glands were isolated from skin biopsy specimens of the forearm, cannulated, and stimulated to secrete sweat. All 14 isolated CF sweat glands failed to respond to ISO + theophylline (TH, as aminophylline), but 17 of 18 control glands responded with a mean rate (SR) of 1.1 nl/min per gland. Cholinergic responsiveness of isolated CF sweat glands was comparable with that of control glands. The in vivo sweat test was performed by intradermal injection in the forearm of 0.2 ml of 2.4 or 8 X l0-' M ISO with or without 10-2 M TH (and 1.4 X l0-4 M atropine as a necessary anticholinergic agent). The beads of sweat secreted into the oil-filled sweat collection ring glued to the skin were then collected with a glass capillary under a stereomicroscope. Of 28 CF patients, 26 failed to show a secretory response to intradermal injection ofISO + TH, and 2 CF patients gave SR of <0.007 nl/min per gland in the first test but no response in the repeat test performed later. In contrast, all 35 age-and sex-matched control subjects responded with the mean SR of 0.72 nl/min per gland. Response of CF patients to epinephrine and phenylephrine was comparable with control, indicating that the alpha adrenergic responsiveness of CF sweat glands is not defective. A preliminary attempt was made to determine tissue cyclic AMP accumulation by radioim- The data suggest that beta adrenergic regulation is abnormal in CF sweat glands and justifies further investigations into the mechanism of beta adrenergic regulation ofthe eccrine sweat gland in both normal and CF subjects.
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Introduction
The eccrine sweat gland has long attracted the attention ofcystic fibrosis (CF)' researchers because the elevated sweat NaCl concentration is the cornerstone of the diagnosis (1) . It appears to be firmly established that the elevated sweat NaCI is due to impairment of the CF sweat duct to reabsorb NaCI from apparently normal primary sweat formed in the secretory portion (2, 3, 4) . In contrast, the function of the secretory portion itself has been assumed to be normal in CF. Recent data from the authors' laboratory indicates that the isolated cannulated monkey palm eccrine sweat gland is controlled by alpha and beta adrenergic as well as cholinergic stimulation (5) . Further, the role of Ca in the intracellular processes during cholinergic sweating and that of intracellular cyclic AMP (cAMP) in the beta adrenergic mechanism of sweating have been suggested (6, 7) . During extension of a similar pharmacological approach to isolated human sweat glands, we fortuitously discovered that isolated, cannulated CF sweat glands failed to secrete sweat in response to isoproterenol (ISO) while their cholinergic responsiveness was apparently normal. We report herein that this defective responsiveness of the CF sweat gland was present in vivo as well as in vitro, although preliminary data indicate that the isolated CF sweat glands accumulated intracellular cAMP apparently normally in response to ISO.
1. Abbreviations used in this paper: AT, atropine; CF, cystic fibrosis; EP, epinephrine; ISO I "% 1 cm long and 0.5 cm wide, were excised from the forearms of 12 physically active adult CF male patients and 14 age-matched equally physically active control males, and the surgical wound was primarily closed with a running subcuticular suture. The direct infusion of lidocaine into the excised skin was avoided. The biopsy skin was blotted of blood, sliced freehand with a razor blade, and washed in several changes of chilled Krebs-Ringer bicarbonate (KRB) solution containing (in mM): 1 5 NaCl,10 Na-acetate, 5 KCI, 1.2 MgCl2, 25 NaHCO3, 1.2 NaH2PO4, 5 glucose, and 10 mg/100 ml fatty acid-free human serum albumin (Sigma Chemical Co., St. Louis, MO). The pH of this medium was 7.45 when equilibrated with 5% C02:95% 02. Single sweat glands were isolated at10C under a stereomicroscope by gently teasing away periglandular collagen fibers with sharp forceps (5) (Fig. 1 A) .
Sweat induction in vitro. The open end of the duct near the junction of the proximal and the distal duct was held by suction in a siliconized constriction pipette as described previously (5) . In some sweat glands, sweat was collected directly from the end of the secretory coil held in a pipette, as shown in Fig. 1 B. Because the ductal reabsorption of water, if any, is not significantly large (5), the ductal sweat was conveniently regarded as the same as true secretory rate and was treated together with the sweat rate obtained directly from the secretory coil. The tissueglass junction inside the constriction pipette was sealed with Sylgard 184 (Dow Coming Corp., Midland, MI), and the pipette was filled with water-saturated paraffin oil. The temperature of the bath (KRB) was then raised from 10 to 370C. Sweat secretion was then initiated by various concentrations of methacholine (MCH). Sweat glands which failed to respond to MCH were discarded because they were most likely damaged during isolation or occluded with tissue debris. In such glands, the proximal tubular lumen was often dilated and/or tiny particles were seen flowing through the lumen proximal to the possible site of damage. Likewise, sweat glands that failed to produce >80% of the control (first) MCH sweat rate upon restimulation (e.g., MCH at 70 min in Fig. 5) were excluded from the study. About 50% of the initially responding glands did not meet this last criterion. The number of sweat glands successfully isolated for the sweat induction study from each skin biopsy varied from zero (in two CF patients) to three (in one CF patient) glands. The data from all sweat glands which met the criteria set forth above were treated together.
Following initial stimulation with MCH, the incubation bath was replaced with several changes of fresh KRB containing 10-' M atropine (AT), which immediately stopped MCH sweating. ISO or EP was then added to the bath at different concentrations with or without 10-' M (or in some glands 10-2 M) TH. Collection of sweat in an oil-filled sampling pipette and calibration of sweat volume are essentially the same as described previously (5) .
Intradermal sweat test in vivo. The anaerobic method of sweat collection (8) was used with minor modifications. Briefly, a teflon ring (sweat collection chamber) with a 7-mm hole in the center was glued to the skin of the forearm using a contact cement (Fig. 2) . Paraffin oil saturated with water was poured into the trough of the chamber. At a room temperature of 240C, no sweat secretion was detected when observed under a stereomicroscope for as long as I h. At time zero, a 30-gauge needle was inserted into the dermis at the center of the test site and 0.2 ml of injection solution was infiltrated so as to cover the test area of 0.38 cm2 with a uniform blanching (injection) wheal (Fig. 2 ).
This is of critical importance with ISO injection because deep or subcutaneous injection can easily produce a false negative sweating response. To insure obtaining the maximal sweat rate, we always performed intradermal injection of adrenergic drugs in duplicate in both control and CF subjects, and employed the higher sweat rate and discarded the other. In other words, a negative response of a CF patient to ISO + TH was always confirmed in duplicate. After injection, beads of sweat secreted into oil were collected with an oil-filled glass pipette and sweat rates calibrated by transferring the sweat sample into a constant bore calibration pipette. The typical time course of sweating response is shown for both MCH and ISO injection in a normal subject (Fig. 3 ). Since the sweating rate for ISO was low, sweat was collected every 10 min, and the first 10 min sweat rate was used as the maximal ISO sweat rate, whereas the MCH sweat rate was determined every 5 min and the maximal sweat rate usually achieved between a 5-and 15-min period. The maximal number of active sweat pores inside the chamber (range 43-113/0.38 cm2) were counted during stimulation with MCH, which was then used to calculate the sweat rate per gland per min. The same maximal pore number during MCH stimulation was used to calculate the ISO-induced sweat rate although the number of active pores tended to be lower during stimulation with ISO with or without TH.
Concentrations of drugs in injection solutions. To circumvent the difficulty in performing a dose-response study in vivo (see Discussion), we used the maximal sweat rate as a practical measure of pharmacological sensitivity and the overall glandular activity of the sweat gland (9) . In preliminary experiments in three control subjects (i.e., a poor sweater, an intermediate sweater, and a heavy sweater, by history), we 1765 Cystic Fibrosis and Sweat Gland 71 injected from 2.5 X 10-3 to 2 X 1-0 M MCH and followed the time course ofsweat response using the modified anaerobic method described earlier.
In all three subjects, we found that 5 X lo-M MCH concentration consistently gave the highest sweat rate, and the higher MCH concentration usually produced comparable or even a lesser sweat rate. Thus, 5 X I0-M MCH was used throughout the study. Concentrations of other drugs used for intradermal injection are listed in Table I . AT (1.4 X 10-4 M) was always injected with adrenergic drugs (i.e., ISO, EP, phenylephrine [PL] ) to inhibit any possible cholinergic component of sweating. A few CF patients did show transient sweating when ISO + TH without AT was injected intradermally. However, this response was totally inhibited by 1.4 X 10-4 M AT. Injection of as high as 10-2 M AT does not influence beta adrenergic responsiveness (n = 6). 10 mM TH included for ISO injection was prepared by adding 5 mM aminophylline (dimer of theophylline bound to ethylenediamine, U. S. Pharmacopeia grade). Injection of 10 mM TH alone failed to cause sweating in control subjects (not illustrated). That TH + ISO injection indeed reflects amplified beta adrenergic stimulation is best shown in Fig. 4 , where propranolol (PR, obtained as Inderal from Ayerst, Inc., New York) inhibited ISO + TH-induced sweating in a dose-related manner. PR (10-5 to 5 X l0-4 M) has no effect on MCH sweating in vitro (5) and in vivo (not shown). Further justification for the use of TH will be discussed in later sections. ISO, EP, PL, and AT were conveniently prepared fresh from injection ampoules (U. S. Pharmacopeia grade) and the MCH solution was prepared at the University of Iowa Hospitals pharmacy by dissolving MCH powder (purchased from Sigma Chemical Co.) in Ringer's solution.
Determination oftissue cAMP level. The methods for incubation of the sweat glands, extraction and reconstitution of cAMP, and determination ofcAMP by radioimmunoassay have been described previously MCH:
order to estimate the extent of loss ofcAMP by adsorption to the tissue, enzymatic degradation by the tissue, or by inefficiency of cAMP extraction, 1-3 pmol of exogenous cAMP were added to both CF and control sweat glands incubated with AT and PR and to appropriate tissue blanks before subjection to cAMP extractions. The estimated loss of exogenous cAMP was <10% in both control and CF glands.
TH was used throughout the study as a phosphodiesterase inhibitor because in our previous study (6) TH was comparable with MIX (1-methyl-3-isobutylxanthine) in vitro. Furthermore, MIX requires the use of organic solvents which could alter cAMP metabolism (I 1) and because the in vitro study could be compared with the in vivo injection study. Unless otherwise stated, all the reagents were obtained from Sigma Chemical Co.
Results
Sweat induction in vitro. Abnormal responsiveness of isolated CF sweat glands was discovered when we started dissecting CF sweat glands and studying their pharmacological responsiveness in vitro in 1980. Fig. 5 illustrates an example ofsuch experiments. After isolating the sweat gland and holding it in a constriction pipette (see Fig. 1 ), the sweat gland was stimulated first with 3 X 10-6 M and then 5 X lO-5 M MCH, both of which induced copious sweat secretion. Then, at "wash," the incubation medium was replaced several times with fresh medium containing IO-' M AT, which completely stopped sweating. As can be seen, subsequent stimulation with varying concentrations of ISO, even with maximal potentiation with 10-2 M TH, failed to induce the secretory response. The lack of secretory response to ISO + AT may not be due to inhibition of glandular function by ISO + TH because addition of 5 X lo-5 M MCH at 70 min induced a maximal response that was then inhibited by 10-6 M AT at 90 min. In contrast, sweat glands from normal controls responded to varying extents to ISO alone (Fig. 6 A) or to ISO + TH (Fig. 6 B and C) . To further elaborate the interaction between ISO and TH, the effect of 10-3 M TH was studied on ISO-induced sweating in 9 control and 12 CF sweat glands (Fig. 7) . None of the CF sweat glands responded to ISO alone or to the combination of ISO and TH, whereas in the control sweat glands, TH markedly augmented ISO-induced sweating in all but one gland. Fig. 8 summarizes the secretory rate ofall the isolated human sweat glands, some of which have already been included in Fig.   7 . As can be seen, the MCH sweat ratemax of CF glands is about two-thirds that of control, i.e., 7 sweat rate increased markedly in all the control subjects so that even those control subjects who failed to respond to ISO alone 1 9) had now responded to the combination of ISO and TH (Fig.  9) . Fig. 10 is the summary of the maximal sweat rate due to intradermal ISO + TH in all the subjects. Note the striking similarity to the in vitro results shown in Fig. 8 . Also, note the lower than control ISO + TH sweat rate in CF heterozygotes, although the overlap with control is not ignorable (Fig. 10) .
Although the mean MCH sweat ratemax in the CF patients was slightly lower than in the controls (7.9±0.66 vs. 5.7±0.60), the (8) wide overlap between the two groups and the extent of individual variation in the controls complicate its interpretation. Table I . The numbers in large parentheses are the no. of subjects studied. Empty symbols are female and the solid symbols are males. Crosses are the means±SEM. 2 of 28 CF patients showed a transient uncollectable amount of sweat secretion (sweat rate < 0.007 nl/gl per min) during stimulation with ISO + TH. The repeated sweat test, however, failed to reproduce this minute ISO-sweating. Asterisk, the number of CF subjects should read 24 if it could later be proven that adrenergic agonists taken by 4 of 28 CF on an infrequent basis during the preceding 2 mo had influenced their sweating response to intradermal ISO (also see footnote 4); CFHZ, cystic fibrosis heterozygotes compared with their age-and sex-matched controls.
(P 2 0.05), nor was the peak level of cAMP level stimulated by both ISO and TH, i.e., at 10 min. The only difference between the two groups is the slower rate of rise of cAMP level in the CF sweat glands when stimulated with both ISO and TH during the first 5 min of incubation (i.e., plots a' and b' in Fig. 12 ). The contribution of contaminating periglandular components, vitro is far more difficult and time-consuming. We have previously suggested (9) that one possible solution to this dilemma is to use the maximal sweat rate per gland as a measure of overall glandular activities because the higher the sweat ratemax per gland or per unit tubular length of the secretory coil, the higher is the pharmacological sensitivity (as defined by the higher affinity constant for MCH, pKA) and the larger is the size of the sweat gland. Since pKA for MCH and perhaps also for ISO differ in different individuals, the only way to insure obtaining the maximal sweat rate from different subjects is to use the supramaximal concentrations for in vivo (see Table I ) and in vitro experiments as done in this study. An erratic or irreproducible sweating response to intradermal injection ofadrenergic drugs has long been known (14) . Although this has been attributed to vasoconstriction caused by (nor)epinephrine or by PL, the erratic response to intradermal injection of ISO (which does not cause vasoconstriction) has been a puzzle. 2 We found that addition of TH to ISO markedly augments beta responsiveness of normal sweat glands both in vivo and in vitro. This supports the generally held theory that beta adrenergic stimulation is mediated by intracellular cAMP levels (6, 10, 15) , and that TH augments the effect of ISO principally by minimizing phosphodiesterase-induced degradation of intracellular cAMP. This interpretation appears also to be true with the sweat gland because (a) TH alone is not sudorific in vivo or in vitro in the human (unpublished data), (b) TH plus ISO-induced sweating is inhibited by PR in a dose-dependent fashion, and (c) TH indeed augmented ISO-induced cAMP accumulation in isolated eccrine sweat glands.
The present study has shown a distinct separation between CF patients3 and their age and sex-matched controls4 in terms of their sudorific response to ISO plus TH both in vivo and in vitro. No CF sweat glands responded to augmented beta adrenergic stimulation, whereas all but one of the control sweat glands did to varying extents. In contrast, the response of CF sweat glands to MCH, EP (alpha and beta adrenergic agonist) and PL (alpha agonist) were comparable with control. These observations indicate that it is only the beta adrenergic component that may be abnormal in the CF sweat gland.
We then made a limited attempt at distinguishing the site of defect in CF, such as beta receptor-agonist interaction, adenylate cyclase, or (increased) phosphodiesterase activity. Contrary to our initial expectation, isolated and incubated CF sweat glands showed normal tissue accumulation of cAMP in response to varying doses ofISO. Furthermore, the maximal tissue cAMP level in CF glands (by ISO + TH at 10 min of incubation in Fig. 12 ) was also comparable with control although the time course of ISO + TH-induced cAMP accumulation during the first 5 min ofincubation was significantly lower than in controls. It is not certain whether this latter observation is relevant to the defective beta adrenergic-induced sweating in CF; however, we are somewhat skeptical of such a possibility because in the in vitro sweat induction study, the CF sweat gland does not respond to ISO + TH at all, even if exposed to these drugs for a prolonged period oftime, i.e., for as long as 30 min. Although the observed cAMP accumulation may largely reflect that in the secretory coil,5 the critical question remains unanswered as to whether the secretory cells (rather than dark cells or myoepithelial cells) are predominantly responsible for cAMP accumulation in both control and CF. Nevertheless, in a recessive disease where an abnormal gene product may presumably be involved regardless of cell types, the measurement of cAMP response in the whole tissue itself may serve an initial screening purpose. Thus, until more refined information becomes available, the present cAMP study should be regarded as tentative in nature.
The present observation has also raised another important issue, that is, how is this defect of the CF secretory coil related to the defective ductal NaCI reabsorption by the CF sweat duct? No speculation on this can be made at this point. An abnormality of autonomic nervous function has frequently been suggested as the possible etiology of CF. Evidence for this possibility includes: chronically reserpinized rats resemble CF in many respects (17, 18); isoproterenol-treated rat was once proposed as a model system for CF (19) ; decreased effect of ISO on the heart rate but an increased sensitivity to PL on pupillary dilation is 5. The whole sweat gland used in this study consists of the duct which occupies -1/3_1/4 of total protein content and the secretory coil (unpublished data). In the monkey sweat glands, an ideal model for human glands both structurally and functionally, both the duct and the secretory coil accumulate cAMP to the same extent when expressed on a per unit protein basis, with and without ISO stimulation (10) . Thus, unless the CF sweat duct produces three-to fourfold more cAMP accumulation (a less likely possibility because the duct is not hypertrophied in CF), the observed cAMP level in Figs. I and 12 should reflect largely that in the secretory coil although this presumption must be confirmed in the future. Furthermore, the present presumption that the secretory cells account in large part for cAMP level in the secretory coil must also be confirmed.
reported in CF (20) ; and ISO-induced cAMP production is decreased (21) and beta adrenergic receptor binding is impaired (22) in CF leukocytes, but a more recent paper (23) reports normal beta adrenergic receptor binding and cAMP response in CF granulocytes. Thus, the present study may complement other related observations in the overall search for the basic defect for this semilethal genetic disease of young children.
